Commonwealth of Pennsylvania Public School Employees Retirement System’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-43,483	Closed	-$165K	–	1648
2020 Q1	$165K	Buy	43,483 +14,182	+48%	+$61.1K	﹤0.01%	1462
2019 Q4	$149K	Sell	29,301 -14	-0%	-$74	﹤0.01%	1525
2019 Q3	$148K	Buy	29,315 +289	+1%	+$1.44K	﹤0.01%	1497
2019 Q2	$179K	Buy	29,026 +8	+0%	+$39	﹤0.01%	1474
2019 Q1	$135K	Buy	29,018 +26	+0.1%	+$118	﹤0.01%	1538
2018 Q4	$122K	Buy	28,992 +8,973	+45%	+$45.7K	﹤0.01%	1520
2018 Q3	$126K	Buy	20,019 +4,425	+28%	+$34K	﹤0.01%	1506
2018 Q2	$125K	Buy	+15,594	New	+$119K	﹤0.01%	1471

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's PGNX Position: Q2 2020 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 43,483 shares — an estimated $165K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in PGNX in Q2 2018 and held it in 8 quarters. The position peaked at $179K in Q2 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Commonwealth of Pennsylvania Public School Employees Retirement System sold 43,483 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $165K.
Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Progenics Pharmaceuticals Inc in Q2 2018 and held it in 8 quarters.
Commonwealth of Pennsylvania Public School Employees Retirement System's Progenics Pharmaceuticals Inc position peaked at $179K in Q2 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q2 2020, filed 11 Aug 2020.